RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
RT @pvilloslada1: 15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials http…
Congrats @pvilloslada1 and the rest of the @Bionure team!
15 years of research yield a new drug for preventing brain damage from MS and glaucoma. Now moving to phase 2 trials https://t.co/c3op4FEmDt